Zobrazeno 1 - 10
of 44
pro vyhledávání: '"MARICA ARVIGO"'
Autor:
Diego Ferone, Richard A Feelders, Fadime Dogan, Peter M. van Koetsveld, Federico Gatto, Eleonora Bruzzone, Leo J. Hofland, Steven W. J. Lamberts, Marica Arvigo, Rob van der Pas
Publikováno v:
Journal of Endocrinology, 245(1), 101-113. Bioscientifica Ltd
Pituitary-directed medical treatment for Cushing’s disease (CD) is currently represented by membrane receptor targeting drugs (somatostatin analogs and dopamine agonists). Somatostatin and dopamine receptors are regulated by β-arrestins, which hav
Autor:
Tullio Florio, Gianluigi Zona, Adriana Bajetto, Marica Arvigo, Diego Criminelli Rossi, Gabriele Gaggero, Diego Ferone, Alessandro Prior, Federica Nista, Claudia Campana, Federico Gatto, Federica Barbieri, Jessica Amarù, Agnese Solari
Publikováno v:
Cancers
Volume 13
Issue 8
Cancers, Vol 13, Iss 1816, p 1816 (2021)
Volume 13
Issue 8
Cancers, Vol 13, Iss 1816, p 1816 (2021)
First-generation somatostatin receptor ligands (fg-SRLs), such as octreotide (OCT), represent the first-line medical therapy in acromegaly. Fg-SRLs show a preferential binding affinity for somatostatin receptor subtype-2 (SST2), while the second-gene
Autor:
Claudia Campana, Diego Ferone, Federico Gatto, Marica Arvigo, Francesco Cocchiara, Jessica Amarù, Federica Nista, Giuliana Corica, Gianluigi Zona, Diego Criminelli Rossi
Context Discordant growth hormone (GH) and insulin-like growth factor-1 (IGF-1) values are frequent in acromegaly. Objective To evaluate the impact of different GH cutoffs on discordance rate. To investigate whether the mean of consecutive GH measure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22d7f80f35ed23a7057ee2d77ddee6a5
http://hdl.handle.net/11567/1044725
http://hdl.handle.net/11567/1044725
Somatostatin receptors (SSTs) are widely co-expressed in pituitary tumors. SST2 and SST5 are the most represented SST subtypes. First-generation somatostatin receptor ligands (SRLs) mainly target SST2, while pasireotide, a multi-receptor ligand, show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728c58be7888f09e1f4591f88b7c2c94
http://hdl.handle.net/11567/1023426
http://hdl.handle.net/11567/1023426
Autor:
Federico Gatto, Massimo Giusti, Mara Boschetti, Eleonora Bruzzone, Francesco Cocchiara, Marica Arvigo, Diego Ferone, Giulia Graziani, Jessica Amarù, Claudia Campana
Pasireotide is a second-generation somatostatin (SRIF) receptor ligand (SRL), approved for medical treatment of acromegaly and Cushing’s disease (CD). The molecule is a stable cyclohexapeptide synthetized based on SRIF structure. Differently from f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfdbe93b597276e12cd99e43919d3ada
https://hdl.handle.net/11567/937621
https://hdl.handle.net/11567/937621
Autor:
Francesco Cocchiara, Carmen Ferrajolo, Carlotta Dell’Aquila, Marica Arvigo, Claudio Cricelli, Gianluca Trifirò, Diego Ferone, Federico Gatto, Francesco Lapi, Claudia Campana, Massimo Giusti
Purpose: Epidemiological data are pivotal for the estimation of disease burden in populations. Aim: Of the study was to estimate the incidence and prevalence of acromegaly in Italy along with the impact of comorbidities and hospitalization rates as c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::834e59572c135beb397834661f6a104e
http://hdl.handle.net/11562/1039565
http://hdl.handle.net/11562/1039565
Autor:
Laura Blackwood, Gianna Baroni, Riccardo Finotello, Rachel Burrow, Lorenzo Ressel, Veronica Marchetti, D Mignacca, Giorgio Romanelli, Marica Arvigo
Publikováno v:
Veterinary and Comparative Oncology. 14:170-180
Insulin-like growth factor type II (IGF-II) is the main cause of non-islet cell tumour hypoglycaemia (NICTH) and insulin is thought to be the only factor causing hypoglycaemia in insulinomas. However, two case reports of pancreatic neuroendocrine tum
Autor:
Diego Ferone, Marica Arvigo, Francesco Minuto, Mara Boschetti, Federico Gatto, Manuela Albertelli
Publikováno v:
Expert Review of Endocrinology & Metabolism. 8:149-157
The actions of somatostatin (SRIF) are mediated by specific G protein-coupled receptors, named SRIF receptor (SSTR) subtypes 1, 2, 3 and 5. SRIF binding to SSTR activates a series of second messenger systems, resulting in the inhibition of calcium ch
Autor:
Diego Ferone, Marica Arvigo, Leila Danesi, Raffaella Radin, Laura Zanaboni, Mara Boschetti, Giovanna Sciortino, Emanuela D'Angelo, Elena Cassinerio, Marina Baldini, Maria Domenica Cappellini, Giovanni Vitale, Agnese Cattaneo, Alberto Giacinto Ambrogio, Paolo Marzullo, Nadia Mirra, Francesco Cavagnini, Massimo Scacchi, Luca Persani
Previous evidence supports a role for growth hormone (GH)-insulin-like growth factor (IGF)-I deficiency in the pathophysiology of osteopenia/osteoporosis in adult thalassemia. Moreover, serum IGF-II has never been studied in this clinical condition.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33efae7fbdeda2783db4429e09914356
http://hdl.handle.net/11567/851013
http://hdl.handle.net/11567/851013
Autor:
Federico Gatto, Marica Arvigo, Mara Boschetti, Eugenia Resmini, Claudia Teti, Francesco Minuto, Diego Ferone, Daniela Esposito
Publikováno v:
Journal of Molecular Endocrinology. 42:361-370
The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas is well established. Indeed, dopamine and somatostatin receptor agonists are considered milestones for the medical therapy of t